|

INCMGA00012 Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Retifanlimab

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Providence Health & Services1
  • Institut Bergonié1

Indications

  • Cancer2
  • Cancer of the Head and Neck1
  • Resectable Sarcoma1

Other1 trial

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)
Phase 2

Portland, Oregon1 trial

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Portland Providence Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.